Cyclic AMP and Calcium in the Transduction of Hypothalamic Neurohormone Action in Human Pituitary Tumors

Hormone Research in Paediatrics

Volumn 47, Issue 4-6, 1997, Pages 235-239

  Spada, Anna ^a   Lania, Andrea ^a   Mantovani, Simona ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Adenylyl cyclase; Calcium; cAMP; Hypothalamic neurohormones; Pituitary tumors

Indexed keywords

CALCIUM; CELL RECEPTOR; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROHORMONE;

CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONFERENCE PAPER; HORMONE RELEASE; HUMAN; HYPERPLASIA; HYPOPHYSIS TUMOR; HYPOTHALAMUS; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

CALCIUM; CYCLIC AMP; HUMANS; HYPOTHALAMIC HORMONES; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PITUITARY NEOPLASMS;

EID: 0030906566     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185469     Document Type: Article

References (38)

1. Asa SL: The role of hypothalamic hormones in the pathogenesis of pituitary adenomas, Pathol ResPract 1991;187:581-583.
2. Spada A, Vallar L, Faglia G: Cellular alterations in pituitary tumors, Eur J Endocrinol 1994:130:43-52
3. Herman-Bonert V, Fagin JA: Molecular pathogenesis of pituitary tumours, Baillicrcs Clin Endocrinol Metab 1995;9:203-223.
4. Faglia G, Spada A: The role of hypothalamus in pituitary neoplasia, Baillicrcs Clin Endocrinol Metab 1995;9:225-242.
5. Melmcd S, Ho K, Klibanski A, Rcichlin S, Thomer M: Recent advances in pathogenesis, diagnosis and management of acromegaly, J Clin Endocrinol Metab 1995:80:3395-3402.
6. Findlay J, Eliopoulos E: Three dimensional modelling of G-protein linked receptors, Trends Pharmacol Sci 1990:11:492-499.
7. Strosberg AD: Structure/function relationship of proteins belonging to the family of reccptors coupled to GTP binding proteins, Eur J Bio-chcm 1991:196:1-10.
8. Bimbaumer L, Abramowitz J, Brown AM: Rc-ceptor-effector coupling by G-proteins, Bio-chim BiophysActa 1990:1031:163-224.
9. Bourne HR, Sanders DA, McCormick F: The GTPase superfamily; a conserved switch for diverse ccll functions, Nature 1990:348: 125-132.
10. Spiegel AM, Shcnker DA, Weinstein LS: Re-ceptor-effector coupling by G proteins: Implication for normal and abnormal transduction, Endocr Rev 1992;13:536-565.
11. Fcderman AD, Conklin BR, Schrader K.A, Reed RR, Bourne HR: Hormonal stimulation of adcnvlyl cyclase through Gi-protein bg subunit, Nature 1992;356:159-162.
12. Clapham DE, Neer EJ: New roles for G-protcin bg-dimcrs in transmcmbranc signalling, Nature 1993;365:403-406.
13. Vallar L, Spada A, Giannattasio G: Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas, Nature 1987; 330:566-567.
14. Landis C, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L: GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumors, Nature 1989:340:692-696.
15. Spada A, Vallar L, Faglia G: G protein oncogenes in pituitary tumors, Trends Endocrinol Metab 1992;3:355-360.
16. Tordjman K, Stem N, Ouaknine G, Yossiphov Y, Razon N, Nordenskjold M: Activating mutations of the Gs a-genc in nonfunctioning pituitary tumors, J Clin Endocrinol Metab 1993; 77:765-769.
17. Bcrtherat J, Chanson P, Montminy M: The cyclic 3',5'-monophosphate-responsive factor CREB is constitutivcly activated in human somatotroph adenomas, Mol Endocrinol 1995:9: 777-783.
18. Wujjelinck T, Wolfman A, Wcbcr M, Sturgill T: Inhibition of EGF-activatcd MAP kinase signaling pathway by adenosine 3'.5'-mono-phosphatc, Science 1993;262:1065-1069.
19. Lin S, Lin C, Gukovsky I, Lusis A, Sawchcnco P, Roscnfcld MG: Molecular basis of little mouse phenotype and implications for cell type-specific growth, Nature 1993:364:208-213.
20. Billestrup N, Mitchell RL, Vale W, Verma IM: Growth hormone releasing factor induces c-fos expression in cultured primary pituitary cells, Mol Endocrinol 1987; 1:300-305.
21. Burton FH, Hascl KW, Bloom FF., Sutcliffe JG: Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene, Nature 1991;350:74-77.
22. Robbcrecht P, Vcrtongen P, Velkeniers B, De Ncef P, Vergani P, Raftopoulos C, Brotchi J, Hooghe-Peters EL, Christophe J: Receptors for pituitary adenylate cyclase activating polypeptide in human pituitary adenomas, J Clin Endocrinol Metab 1993;77:1235-1239.
23. Lania A, Gil-dcl-Alamo P, Saccomano K, Per-sani L, Faglia G, Spada A: Mechanism of action of pituitary adenylate cyclase-activating polypeptide (PACAP) in human nonfunctioning pituitary tumors, J Neuroendocrinol 1995; 7:695-702.
24. Spengler D, Waeber C, Pantaloni C, Holsbocr F, Boackaert J, Seeburg PH, Journot L: Differential signal transduction by five splice variants of the PACAP receptor, Nature 1993:365: 170-175.
25. Lamberts SWJ: The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors, Endocr Rev 1988: 9:417-435.
26. Wood DF, Johnston M, Johnston DG: Dopamine, the dopamine D2 receptor and pituitary tumors, Clin Endocrinol (Oxf) 1991:35:455-466.
27. Vallar L, Mcldolcsi J: Mechanisms of signal transduction at the D2 receptor, Trends Pharmacol Sci 1989;10:74-77.
28. Rcisine T, Bell GI: Molecular biology of somatostatin receptors, Endocr Rev 1995; 10: 427- 442.
29. Spada A, Bassctti M, Reza-Elahi F, Arosio M, Gil-del-Alamo P, Vallar L: Differential transduction of dopamine signal in different subtypes of human GH-secrctingadenomas, J Clin Endocrinol Metab 1994;78:411-417.
30. 1* concentration decrease in GH4CI cells, J Biol Chem 1990; 265:10320-10326.
31. 2* levels and adenylyl cyclase activity in human nonfunctioning pituitary adenomas, J Clin Endocrinol Metab 1991;73:913-918.
32. 2* in human adenomatous lacto-trophs, J Endocrinol Invest 1990; 13:13-18.
33. McArdle CA, Poch A, Schomerus E, Kratz-meier M: Pituitary adenylate cyclase activating polypeptide effects in pituitary cells: modulation by gonadotropin-releasing hormone in aT3-I cells, Endocrinologv 1994; 134:2599-2605.
34. Chen C, Vincent JD, Clarke IJ: Ion channels and the signal transduction pathways in the regulation of growth hormone secretion, Trends Endocrinol Metab 1994:5:227-233.
35. Grcenman Y, Melmcd S: Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors, J Clin Endocrinol Metab 1994:78:398-403.
36. Greenman Y, Melmcd S: Expression of three somatostatin receptor subtypes in pituitary adenomas; evidence for preferential SSTR5 expression in the mammosomatotroph lineage, J Clin Endocrino! Metab 1994:78:724-729.
37. Panctta R, Patel YC: Expression of mRNA for all five somatostatin receptors (hSSTRl-5) in pituitary tumors, Life Sci 1994:56:333-342.
38. Miller GM, Alexander JM, Bikkal HA, Katz-nclson L, Zervas NT, Klibanski A: Somatostatin receptor subtype gene expression in pituitary adenomas, J Clin Endocrinol Metab 1995;80:1386-1392.